论文部分内容阅读
<正> Purpose: To compare the intraocular pressure (IOP)-lowering efficacy of topically administered bimatoprost 0.03% with la-tanoprost 0.005% in patients with ocular hypertension (OHT) or glaucoma. Design: Multicenter, investigator-masked, 6-month r